rs237026

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001292034.3(TAB2):​c.1939+361G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.627 in 151,296 control chromosomes in the GnomAD database, including 32,173 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 32173 hom., cov: 29)

Consequence

TAB2
NM_001292034.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0570

Publications

9 publications found
Variant links:
Genes affected
TAB2 (HGNC:17075): (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
TAB2 Gene-Disease associations (from GenCC):
  • chromosome 6q24-q25 deletion syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • congenital heart defects, multiple types, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • polyvalvular heart disease syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.894 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001292034.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAB2
NM_001292034.3
MANE Select
c.1939+361G>A
intron
N/ANP_001278963.1
TAB2
NM_001369506.1
c.1939+361G>A
intron
N/ANP_001356435.1
TAB2
NM_015093.6
c.1939+361G>A
intron
N/ANP_055908.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAB2
ENST00000637181.2
TSL:1 MANE Select
c.1939+361G>A
intron
N/AENSP00000490618.1
TAB2
ENST00000470466.5
TSL:1
n.*538+361G>A
intron
N/AENSP00000432709.1
TAB2
ENST00000367456.5
TSL:5
c.1939+361G>A
intron
N/AENSP00000356426.1

Frequencies

GnomAD3 genomes
AF:
0.626
AC:
94687
AN:
151178
Hom.:
32114
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.901
Gnomad AMI
AF:
0.411
Gnomad AMR
AF:
0.586
Gnomad ASJ
AF:
0.473
Gnomad EAS
AF:
0.716
Gnomad SAS
AF:
0.589
Gnomad FIN
AF:
0.538
Gnomad MID
AF:
0.443
Gnomad NFE
AF:
0.490
Gnomad OTH
AF:
0.600
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.627
AC:
94811
AN:
151296
Hom.:
32173
Cov.:
29
AF XY:
0.628
AC XY:
46396
AN XY:
73890
show subpopulations
African (AFR)
AF:
0.901
AC:
37228
AN:
41302
American (AMR)
AF:
0.587
AC:
8916
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.473
AC:
1638
AN:
3462
East Asian (EAS)
AF:
0.715
AC:
3642
AN:
5096
South Asian (SAS)
AF:
0.589
AC:
2826
AN:
4800
European-Finnish (FIN)
AF:
0.538
AC:
5590
AN:
10390
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.490
AC:
33203
AN:
67748
Other (OTH)
AF:
0.605
AC:
1266
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1486
2973
4459
5946
7432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.563
Hom.:
3230
Bravo
AF:
0.645
Asia WGS
AF:
0.725
AC:
2497
AN:
3450

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.49
DANN
Benign
0.24
PhyloP100
0.057
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs237026; hg19: chr6-149720681; API